FTC v. Amgen/Horizon: FTC’s Pursuit of a Novel Theory Signals Greater Scrutiny on the Horizon for Pharmaceutical Mergers
On May 16, 2023, the Federal Trade Commission sued to block Amgen Inc.’s purchase of Horizon Therapeutics plc, showing that the agency...
